- Home
- AOS vs QGEN Comparison
AOS vs QGEN Comparison
Compare AOS & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AOS
- QGEN
- Stock Information
- Founded
- AOS 1874
- QGEN 1986
- Country
- AOS United States
- QGEN Netherlands
- Employees
- AOS N/A
- QGEN N/A
- Industry
- AOS Industrial Machinery/Components
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AOS Industrials
- QGEN Health Care
- Exchange
- AOS Nasdaq
- QGEN Nasdaq
- Market Cap
- AOS 9.7B
- QGEN 10.7B
- IPO Year
- AOS N/A
- QGEN 1996
- Fundamental
- Price
- AOS $65.39
- QGEN $43.78
- Analyst Decision
- AOS Buy
- QGEN Buy
- Analyst Count
- AOS 6
- QGEN 7
- Target Price
- AOS $78.00
- QGEN $50.68
- AVG Volume (30 Days)
- AOS 1.3M
- QGEN 1.0M
- Earning Date
- AOS 10-28-2025
- QGEN 11-04-2025
- Dividend Yield
- AOS 2.21%
- QGEN 3.42%
- EPS Growth
- AOS N/A
- QGEN 405.09
- EPS
- AOS 3.70
- QGEN 1.69
- Revenue
- AOS $3,830,100,000.00
- QGEN $2,040,067,000.00
- Revenue This Year
- AOS $2.77
- QGEN $7.37
- Revenue Next Year
- AOS $4.20
- QGEN $5.65
- P/E Ratio
- AOS $17.59
- QGEN $26.98
- Revenue Growth
- AOS N/A
- QGEN 5.15
- 52 Week Low
- AOS $58.83
- QGEN $37.63
- 52 Week High
- AOS $77.92
- QGEN $51.88
- Technical
- Relative Strength Index (RSI)
- AOS 31.92
- QGEN 29.17
- Support Level
- AOS $64.92
- QGEN $43.26
- Resistance Level
- AOS $66.32
- QGEN $47.39
- Average True Range (ATR)
- AOS 1.53
- QGEN 1.09
- MACD
- AOS -0.30
- QGEN -0.56
- Stochastic Oscillator
- AOS 4.33
- QGEN 6.32
About AOS A.O. Smith Corporation
A.O. Smith manufactures a broad lineup of water heaters, boilers, and water treatment products. The company has two reporting segments: North America (75% of sales) and rest of world (25% of sales). A.O. Smith is the leading manufacturer of water heaters in North America for the residential and commercial markets, with approximately 37% and 54% market share, respectively. Residential water heaters account for most of North American sales and are distributed equally through wholesale and retail channels. Most of A.O. Smith's international revenue is from China, a market the company entered during the mid-1990s. However, the firm announced a strategic review of its China operations.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).